Bmg Pharma S P A

FDA Filings

This page includes the latest FDA filings for Bmg Pharma S P A. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

• Registration Number: 3010580808
• FEI Number: 3010580808
• Name: Michael Killeen
• Owner & Operator: BMG Pharma SpA
• Contact Address: Via Federico Confalonieri, 29 ; Milano IT-25 Lombardia 20124 IT
• Official Correspondent:
  • Annalisa Cavalli
  • 39-029-1321756-x
• US Agent:
  • Michael Killeen
  • 214 7046473
  • mike.killeen@bmgpharma.com
• Registration Status: 1
• Initial Importer: N
• Registration Expiration: 2020-04-25
• Registration Address: 1312 Coral Dr ; Coppell, TX 75019 US
• Establishment Type: Develop Specifications But Do Not Manufacture At This Facility

FDA Filings

Device Company	Device	Date
PMN K081372 | MGQ Michael Killeen [BMG Pharma SpA]	GelX Oral Gel	2013-10-30